Advertorial: Introducing the New Generation Tranexamic Acid Peel

Published

Written by...

Share this article

Pigmentation disorders are a significant concern for patients, with research indicating that 23.6% of men and 29.9% of women seek dermatological care primarily to combat discolouration.1

To support professionals in effectively addressing melasma, post-inflammatory hyperpigmentation or age-related discolouration, medical-grade skincare brand AlumierMD continues to innovate its professional range. Harnessing the power of nature with its new peel, designed to both prevent and correct discolouration.
Radiant TXA Peel is a breakthrough professional treatment combining the triple-action brightening power of 1.95% tranexamic acid (TXA) with the gentle exfoliating action of 30% lactic acid, and the brightening properties of white shiitake mushroom extract.
Skin and medical aesthetic expert Dr Nina Bal, founder of Facial Sculpting by Dr Nina Bal “Tranexamic acid is a game-changer for modern skincare,” says leading aesthetic practitioner Dr Nina Bal, founder of Facial Sculpting by Dr Nina Bal.
She shares, “It is not just brilliant for its brightening effects, but for its ability to act as a barrier against inflammation – a key factor when it comes to pigmentation. By targeting the…

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.